Wooil KWON
Surveillence strategy based on the natural course of IPMN: How often and until when?
8:30-8:50 / BP SY 3-1
Surveillence strategy based on the natural course of IPMN: How often and until when?
8:30-8:50 / BP SY 3-1
Takao OHTSUKA
What is new in revised guidelines: Indications and timing of surgery.
8:50-9:10 / BP SY 3-2
What is new in revised guidelines: Indications and timing of surgery.
8:50-9:10 / BP SY 3-2
Chang Moo KANG
Adjuvant chemotherapy for resected invasive IPMN. Do we have evidence comparing with typical pancreatic cancer?
9:10-9:30 / BP SY 3-3
Adjuvant chemotherapy for resected invasive IPMN. Do we have evidence comparing with typical pancreatic cancer?
9:10-9:30 / BP SY 3-3
Christopher WOLFGANG
Recent updated biomarkers to predict malignant changes of IPMN
9:30-9:50 / BP SY 3-4
Recent updated biomarkers to predict malignant changes of IPMN
9:30-9:50 / BP SY 3-4